Cases selected for the AskAnzal weekly PMCPA insight newsletter
A pharmacist challenged an Actonel leavepiece citing NICE July 2008. The Panel found the title and quotations misleading,…
A pharmacist alleged a Crestor journal ad implied NICE cholesterol targets had been reduced and omitted first-line NICE…
A hospital doctor alleged a Lundbeck rep made a joint visit with a competitor rep and discussed rival…
Anonymous complaint alleged sales reps used an βOncology Product Pipeline Updateβ to promote unlicensed products. Panel found reps…
Ex-employee alleged portfolio βbundlingβ created an incentive to prescribe Botox. PMCPA found the arrangements were terms of trade…
Anonymous pharmacist alleged an Apo-go nurse advisor changed Parkinsonβs medicines without authority and failed to inform PDNSs. Panel…
Anonymous complaint about a Novo Nordisk symposium invitation email. Most allegations were not upheld, but the opt-in wording…
GSK admitted two Benlysta promotional case studies were emailed to 48 HCPs before certification. Emails lacked integral prescribing…
ESMO booth materials for Navelbine were in scope of the UK Code. βRare cumulative toxicityβ and βeasily manageable…
Merck Seronoβs UK press release on FIRE-3 claimed Erbitux extended survival by 7.5 months. PMCPA found the headline,…
One real case. One key lesson. Every week β free.